Generative AI analytics firm GenIP is nearing $1 million in total orders since the company was listed in London last year.
An announcement released on Tuesday revealed the AI company has won orders totalling more than $850,000 since its IPO in October 2025, following the expansion into Chile with an order for 30 analytical assessments from a leading research organisation.
“I am delighted to announce another new international contract with a leading research university, marking GenIP’s first entry into the Chilean market,” said Melissa Cruz, CEO of GenIP.
“The institution has purchased 30 Invention Evaluator assessments, to support technology commercialisation decisions across its research portfolio. This milestone strengthens GenIP’s growing footprint in Latin America and underscores global demand for its GenAI-enabled services.”
GenIP’s move into Chile comes as part of a wider expansion into Latin America, which includes a recent deal with a government agency in Brazil.
The number of orders received since GenIP’s IPO has picked up pace in recent months, with large contracts from clients in Saudi Arabia and Singapore.
Providing insight into the company’s cost base and expansion plans, Cruz continued to explain GenIP’s financial position, highlighting that a large proportion of last year’s costs were related to the IPO and would not recur.
“GenIP’s global expansion is underpinned by a healthy balance sheet that allows the Company to capitalise on opportunities as they arise,” Cruz said.
“As outlined in our audited results, the reported Operating Loss of $888,545 included $358,924 of share-based payments relating to the IPO that are not expected to recur. Customers typically pay in advance for Invention Evaluator report orders, providing the Company with operating cash flow and future revenue visibility, with revenue recognised upon completion and delivery of the report to the client. These factors help maintain the Company’s strong financial position.”